Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy

Advances in Experimental Medicine and Biology

Volumn 576, Issue , 2006, Pages 327-337

  Thomas, Ajit G ^b   Wozniak, Krystyna M ^b   Tsukamoto, Takashi ^b   Calvin, David ^b   Wu, Ying ^b   Rojas, Camilo ^b   Vornov, James ^b   Slusher, Barbara S ^a  

^a GUILFORD PHARMACEUTICALS INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934438627     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-30172-0_24     Document Type: Conference Paper

References (24)

1. Curatolo, A., D'Arcangelo, P., Lino, A. & Brancati, A., 1965, Distribution of N-Acetyl-Aspartic and N-Acetyl-Aspartyl-Glutamic Acids in Nervous Tissue, J Neurochem. 12: 339-42.
2. Neale, J. H., Bzdega, T. & Wroblewska, B., 2000, N- Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system, J Neurochem. 75: 443-52.
3. Coyle, J. T., Stauch-Slusher, B., Tsai, G., Rothstein, J. D., Meyerhoff, J. L., Simmons, M., Blakely, R. D. (1991). In Excitatory Amino Acids, Vol. 69. Raven Press, Ltd.
4. Robinson, M. B., Blakely, R. D., Couto, R. & Coyle, J. T., 1987, Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain, J Biol Chem. 262: 14498-506.
5. Carter, R. E., Feldman, A. R. & Coyle, J. T., 1996, Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase, Proc Natl Acad Sci U S A. 93: 749-53.
6. Chang, S. S., O'Keefe, D. S., Bacich, D. J., Reuter, V. E., Heston, W. D. & Gaudin, P. B., 1999, Prostate-specific membrane antigen is produced in tumor-associated neovasculature, Clin Cancer Res. 5: 2674-81.
7. Heston, W. D., 1997, Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase, Urology. 49: 104-12.
8. Cassidy, M. & Neale, J. H., 1993, N-acetylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia, Neuropeptides. 24: 271-8.
9. Slusher, B. S., Robinson, M. B., Tsai, G., Simmons, M. L., Richards, S. S. & Coyle, J. T., 1990, Rat brain N-acetylated alpha-linked acidic dipeptidase activity. Purification and immunologic characterization, J Biol Chem. 265: 21297-301.
10. Pinto, J. T., Suffoletto, B. P., Berzin, T. M., Qiao, C. H., Lin, S., Tong, W. P., May, F., Mukherjee, B. & Heston, W. D., 1996, Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells, Clin Cancer Res. 2: 1445-51.
11. Doble, A., 1999, The role of excitotoxicity in neurodegenerative disease: implications for therapy, Pharmacol Ther. 81: 163-221.
12. Wroblewska, B., Wroblewski, J. T., Pshenichkin, S., Surin, A., Sullivan, S. E. & Neale, J. H., 1997, N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells, J Neurochem. 69: 174-81.
13. Xi, Z. X., Baker, D. A., Shen, H., Carson, D. S. & Kalivas, P. W., 2002, Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens, J Pharmacol Exp Ther. 300: 162-71.
14. Bruno, V., Battaglia, G., Copani, A., Giffard, R. G., Raciti, G., Raffaele, R., Shinozaki, H. & Nicoletti, F., 1995, Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration, Eur J Neurosci. 7: 1906-13.
15. Jackson, P. F., Cole, D. C., Slusher, B. S., Stetz, S. L., Ross, L. E., Donzanti, B. A. & Trainor, D. A., 1996, Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase, J Med Chem. 39: 619-22.
16. Rojas, C., Frazier, S. T., Flanary, J. & Slusher, B. S., 2002, Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay, Anal Biochem. 310: 50-4.
17. Tiffany, C. W., Cai, N. S., Rojas, C. & Slusher, B. S., 2001, Binding of the glutamate carboxypeptidase II (NAALADase) inhibitor 2-PMPA to rat brain membranes, Eur J Pharmacol. 427: 91-6.
18. Jackson, P. F. & Slusher, B. S., 2001, Design of NAALADase inhibitors: a novel neuroprotective strategy, Curr Med Chem. 8: 949-57.
19. Slusher, B. S., Vornov, J. J., Thomas, A. G., Hurn, P. D., Harukuni, I., Bhardwaj, A., Traystman, R. J., Robinson, M. B., Britton, P., Lu, X. C., Tortella, F. C., Wozniak, K. M., Yudkoff, M., Potter, B. M. & Jackson, P. F., 1999, Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury, Nat Med. 5: 1396-402.
20. Majer, P., Jackson, P. F., Delahanty, G., Grella, B. S., Ko, Y. S., Li, W., Liu, Q., Maclin, K. M., Polakova, J., Shaffer, K. A., Stoermer, D., Vitharana, D., Wang, E. Y., Zakrzewski, A., Rojas, C., Slusher, B. S., Wozniak, K. M., Burak, E., Limsakun, T. & Tsukamoto, T., 2003, Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor, J Med Chem. 46: 1989-96.
21. Ghadge, G. D., Slusher, B. S., Bodner, A., Canto, M. D., Wozniak, K., Thomas, A. G., Rojas, C., Tsukamoto, T., Majer, P., Miller, R. J., Monti, A. L. & Roos, R. P., 2003, Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models, Proc Natl Acad Sci U S A. 100: 9554-9.
22. Bennett, G. J. & Xie, Y. K., 1988, A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain. 33: 87-107.
23. Hargreaves, K., Dubner, R., Brown, F., Flores, C. & Joris, J., 1988, A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain. 32: 77-88.
24. Urazaev, A. K., Buttram, J. G., Jr., Deen, J. P., Gafurov, B. S., Slusher, B. S., Grossfeld, R. M. & Lieberman, E. M., 2001, Mechanisms for clearance of released N-acetylaspartylglutamate in crayfish nerve fibers: implications for axon-glia signaling, Neuroscience. 107: 697-703.